Background: it's well known that diabetic patients are more prone to infection. In these patients, chronic infections are frequent and severe due to impairment of their immune system. The relationship between H. pylori infection and diabetes mellitus have shown in some studies but the relationships remain controversial.
INTRODUCTION
Diabetes mellitus is a disease known for production of chronic complications in diabetic patients (1) . Type 2 diabetes is an emerging pandemic, with 3.8 million deaths in adult attributed to the disease (2) . Infection with H. pylori is acquired in early childhood and if left untreated it becomes a chronic infection (3) . The majority of infected people remain asymptomatic while only a small proportion develops illness and this is usually in adulthood (4) . Infection with H. pylori causes gastric and duodenal ulcers and it increase risk of gastric cancer (5) , also it increase the likelihood of gastric lymphoma (6) . Moreover positive association between H. pylori and extragastric manifestations as iron deficiency anaemia (7) and idiopathic thrombocytopenic purpura (8) have been reported.
Strains of H. pylori play role in the homeostasis of leptin and ghrelin, these 2 hormones are critical to energy homeostasis and metabolism. Infection with H. pylori is associated with chronic inflammation particularly among strains of H. pylori which contain the cag antigen. However, there is evidence that this inflammation may extend beyond the (GIT) to affect insulin and glucose metabolism (9) .
In recent years there is a significant association has been reported between H. pylori infection and cardiovascular disease, diabetes and dyslipidemia (10) . However there are conflicting reports (11) . Reports concerning association between H. pylori infection and various clinical manifestations of the metabolic or insulinresistant syndrome are conflicting (12) . The roles of infection with H. pylori in CVD, and its risk factor (13) and in type 2 diabetes mellitus are not clear.
 Questionnaire
We assessed the GI symptoms of patients using "The GI symptom Questionnaire," which was designed based on The (GSRS) GIT symptom rating scale and the Rome III criteria for functional GI disorders (18) .
The questionnaire is including questions about (GI) symptoms (frequency, strength, and patterns of GI symptoms), lifestyle, social activities, history of disease, visits to a hospital or clinic, and medications.
For diabetic patients the questionnaire had more questions related to diabetes and specifically disease duration, glucose monitoring, treatment, and diabetic complication.
On other hand the health status was assessed by recording their pulse, blood pressure, lower limb edema, height and weight with measurement of body mass index (BMI). Chest and heart examination were done for exclusion of other causes of gastritis and for detection of any abnormalities in heart. Abdomen examination detect the presence of any organomegaly and free intraperetonial fluid.
Data Collection Procedure 1. For the assessment of diabetes mellitus we had taken venous blood sample and send to laboratory for fasting blood sugar (FBS) level, 2 hour-post prandial blood sugar (2h-PPBS), random blood sugar (RBS) level, glycosylated hemoglobin (HBA1c) and 75-g oral glucose tolerance test.
2. For detection of Helicobacter pylori infection we advised the participants for collection of stool sample and send to laboratory for Helicobacter pylori stool antigen (HpSA) by Enzyme immunoassay (EIA).
H.pylori stool antigen (HpSAg) test:
The new enzyme linked immunoassay Helicobacter pylori stools antigen (HpSA) is a highly sensitive and specific, non-invasive diagnostic tool for the detection of H. pylori, even for monitoring the efficacy of treatment. It is not time consuming and cheap (19) . 
STATISTICAL ANALYSIS
The collected data was organized, tabulated and statistically analyzed using spss software version for quantitative data, the range, mean and standard deviation were calculated. For qualitative data comparison between two groups was done using chi -square test (χ²). For comparison between mean of two groups student ttest was used. For comparison between more than two means the F value of analysis of variance and schafee test was calculated. By comparison among diabetic patients in relation to detection of H. pylori infection as regards gastrointestinal symptoms, there was insignificant difference of GIT symptoms between H.pylori +ve /-ve diabetic patients. As shown in table (2). Glycosylated Hb was higher among positive cases, but yet not significant, p 0.07. Also, FBS (p 0.08) and 2h-PPBS (p 0.1) were not significant. As shown in table (3). We found statistically significant increase in H. pylori infection with increase age (p < 0.001), so increase in age is related to increase H. pylori infection. As shown in table (5). In our study we demonstrate that increase in H pylori infection with increase of BMI and this was statistically significant (p < 0.001). So, there is positive between H pylori and BMI. As shown in table (6). By comparison between H.pylori (+ve) cases among the studied groups as regards sex, there was statically insignificant difference. (P 1.0) (NS). As shown in figure (1).
RESULTS

In
Fig. 1. value of H.pylori (+ve) cases among all studied groups in relation to gender.
DISCUSSION
It's well known that diabetic patients are more prone to infection, in these patients chronic infections are frequent and severe due to impaired their immune status (21) . Its now broadly accepted that H. pylori infection is one of the most common chronic infections worldwide (22) . Infections with H. pylori affect approximately 50% of the world population (23) There is a controversy about the relationship between diabetes mellitus (DM) and H. pylori infection (24) . In some studies there is a high prevalence of H. pylori infection in diabetic patients with either type 1 (25) or type 2 DM (26) . In contrast other studies showed there is no association between H. pylori infection and DM, as there is no difference in prevalence of H. pylori infection between diabetic and non-diabetic (27) , regardless of the type (28) , and duration of diabetes (29) and/or severity of dyspeptic symptoms in diabetic patients (28) .
Kojeky, et al, (1993) reported that a significantly lower incidence of H. pylori infection in diabetic patients with active duodenal ulceration, in comparison with non-diabetics (30) .
Also there is controversy about the relationship between gastrointestinal symptoms in diabetes and H. pylori infection. According to some studies, concerning the prevalence of H. pylori related gastro-duodenal disorders; there is no difference between diabetic and non-diabetics (27) . Moreover infection with H. pylori was not associated with upper GI symptoms in diabetics (31 Therefore the prediction of precise prevalence of H. pylori infection in diabetic patients (type 1 and type 2) is required to be investigated, and to determine the relationship between H. pylori infection and GI symptoms among diabetic patients.
Our study was conducted on 100 Participants. Participants were divided into two groups, group I: include 50 diabetic patients ( subjects of type 1 DM and subjects of type 2 DM) with dyspeptic symptoms, group II: include 50 subjects non diabetic control group with dyspeptic symptoms.
The present study aimed to determine the prevalence of H. pylori infection in patients with type 1 & type 2 diabetes mellitus and to detect the relation of H. pylori infection and diabetes.
(HpSAg) test was used to detect Helicobacter pylori infection.
The specific advantages of HpSA assay include: 1. A more simple sampling method (only one stool specimen is required) and relatively cheap (32). 2. The lack of a requirement for trained personnel at the testing site.
3. There is no need for expensive equipment as well as indicating the presence of a current active infection; the stool antigen test is very helpful in the diagnosis of H. pylori in children (33) .
It was found that the prevalence of H. pylori infection between control (50%) and diabetic patients (64%) are statistically insignificant (p 0.36), although diabetics have 14% higher prevalence of H. pylori infection than control group.
A cross-sectional study from Greece by Anastasios et al (2002), study included 172 dyspeptic patients (67 diabetic and 105 non-diabetic), upper endoscopy was done for all patients and H. pylori was detected by histopathological examination. Who reported that the difference of H. pylori prevalence between the diabetic and non-diabetic groups with dyspeptic symptoms was not significant (P 0.78) (27) .
On the other hand the higher prevalence of H. pylori infection in diabetes mellitus with dyspepsia than in non-diabetics was reported in a study in Japan conducted by Kimiaki al (1999) (34) and another study in Italy by Marrollo et al (2001) (35) that conducted on 74 diabetic patients with dyspepsia and 117 non diabetic dyspeptic patients, with assessment of presence and severity of dyspeptic symptoms for each patient. All patients underwent upper gastrointestinal endoscopy with biopsy and Helicobacter pylori were evaluated by rapid urease test and histology (Giemsa).
Many authors reported higher prevalence of H. pylori infection among patients with diabetes, suggesting that reduced gastric motility and peristalsis activity (24) .
However, one study even showed a lower sero-prevalence of H. pylori infection in patients with diabetes mellitus, in comparison with the healthy population Zelenkova et al (2002) . This study conducted on 95 diabetic patients (type I and II) and 216 blood donors, levels of IgG antibodies were determined by ELISA method, who found significant differences in sero-prevalence among the group of diabetic patients (27%) and non diabetic blood donors (5 l%) p< 0.001 (36) . The presence of micro-angiopathy in patients with DM may be a negative factor for colonization by H. pylori because micro-vascular changes in the gastric mucosa may create an unfavorable environment for the establishment or survival of H. pylori (36) .
As regard to the relationship between gastrointestinal symptoms in DM and H. pylori infection. Our findings confirmed that the prevalence of GI symptoms in HP +ve and -ve diabetics patients was statistically insignificant. Although, there is increased severity of dyspepsia, heartburn and bloating in diabetic patients more than control. This would be attributed to poor glycemic control and diabetic autonomic neuropathy.
This agreed with a study by Anastasios et al (2002) that reported there is no difference between diabetics and non-diabetics concerning the prevalence of H. pylori-related gastro-duodenal disorders (27) .
Also, Harry et al (2001) confirmed that by a study conducted on 429 patients with type 1 (n = 49) or type 2 (n = 380) diabetes mellitus (48.6% women, mean age 60.7 yr) and 170 non-diabetic controls (34.7% women, mean age 60.4 yr). Blood sample was tested for H. pylori infection using a validated ELISA kit. The Seroprevalence of H. pylori was 33% and 32%, respectively, in patients with diabetes and controls; the difference was (NS). Upper GI symptoms were present in 49% H. pylori -positive and 53% of H. pylori -negative patients with diabetes (p 0.56) (NS) (37) .
On the contrary, a study by Marrollo et al., (2001) reported that H. pylori infection significantly associated with the presence of endoscopic lesions and chronic gastritis in diabetic patients (35) .
Moreover, Papamichael et al (2009) reported that high prevalence of esophagitis and peptic ulcer was found in H. pylori+ve patients with DM, especially those with cardiovascular autonomic neuropathy (24) .
Also, Gulcelik et al (2005) reported that there is a high prevalence of H.pylori infection in diabetic patients and it is correlated with dyspeptic symptoms in patients with diabetic autonomic neuropathy (26) . Charles and Anthonia (2007) reported that in general gastrointestinal ( GI ) symptoms and GI complications of DM often involve the esophagus, stomach, gallbladder, intestines, and the pancreas. The symptoms include constipation, faecal incontinence, dysphagia, heartburn, abdominal pain, diarrhea and nausea/vomiting. These have been attributed to altered intestinal motility and augmented visceral sensitivity in different regions of the GIT resulting from autoimmune neuropathy, neuroendocrine transmitter imbalance and microangiopathy (38) .
In our study, there was statistically significant difference in mean value of age in relation to prevalence of H. pylori infection. The majority of the patients with H. pylori infection in both groups-diabetic and non diabetic were more than 50 years of age.
Similarly, in a study by devrajani et al (2010) who reported that the prevalence of H. pylori infection in both groups, diabetic and non diabetic, were male more than 50 years old (39) . Also, another study performed by Ugwu et al (2008) has shown that the majority of H. pylori infected patients were more than 60 years of age (40) .
On other hand lower prevalence rate of H. pylori in elderly has been reported in Pilotto et al (2006) and two hypothesis have been advanced to explain these finding, first: As H. pylori could be present in small number which may not detected by histological examination contribute to decrease of sensitivity to many techniques used for detection of H. pylori including histology. The reason for in old age was explained as with advancing age of patients, H. pylori shows progressive proximal gastric migration which initially appears to colonize the antral region, later the body region, while remaining in elderly patients only in the body and fundus of the stomach. So in this condition reduce the sensitivity not only the rapid urease test but also other histological examination when done only on antral biopsy. Second H. pylori could present in past but eliminated through development of unfavorable gastric environment (41) .
This disagreed with our study that reported that the infection by helicobacter pylori increase in elderly with increase of age due to decrease immune status of the body and increase susceptibility for infection.
Our study showed no statistically significant difference between males and females in H.pylori infection. This agreed with shahana et al (1996) (42) , but disagreed with a study by Kanbay et al (2005) (43) , that reported the Helicobacter pylori infected females were predominant as compared to males, while in another study by devrajani et al (2010) (39) confirmed that Helicobacter pylori infection were predominant in males.
There were no statistically significant difference between the rate of H. pylori infection and the increased duration of diabetes. This agrees with a study by Ko et al (2001) (44) but disagree with a study from Italy by Marrollo et al (2001) (35) reported that the rate of H. pylori infection increased with increase duration of diabetes 1 year was 23 % ; 1-3 years was 32% and more than 3 years was 40%.
Our data reported that the prevalence of H.pylori infection increased in obese patients. This is agreed with Bytzer et al (2002) (45) who reported that the prevalence of H. pylori infection might be increase in type 2 DM obese patients as compared to normal.
Furthermore, in a study by Perdichizzi et al (1996 ) , there was a higher prevalence of H. pylori infection both in obese and in diabetic patients with respect to control subjects. Both obesity and type II diabetes may be associated with an increased incidence of H. pylori-colonization. This could be related to the reduced gastric motility and chemical changes in gastric mucosa following non-enzymatic glycosylation processes (46) . Also Papamichael el al (2009) (24) and Arslan et al (2009) (47) considered that obesity can be a risk factor for H. pylori infection.
In contrast, in an American study by loannou et al (2005) showed that H. pylori seropositivity had no statistically significant relation to body mass index or fasting serum leptin level (48) .
A study by Fujiwara et al (2002) Found that eradication of Helicobacter pylori reduce ulcer recurrence in patients with peptic ulcer disease, and improve the quality of life but also associated with increase of body mass index (49) .
Another study reported that H. pylori causes changes in leptin levels and plasma levels of ghrelin and eradication of H. pylori infection can increase appetite leading to rise in body mass index due to a higher caloric intake (50) In our study fasting blood glucose level, 2h postprandial blood glucose concentration and HbAlc in relation to H. pylori infection were statistically insignificant. This is disagreed with Arslan et al (2009) who had shown that patients infected with H. pylori had higher mean fasting and 2h postprandial blood glucose concentration than non-infected diabetics (47) .
On the other hand, the Chinese study by Ko et al ( 2004 ) that shown the women infected with H. pylori had lower mean fasting and 2h postprandial blood glucose concentration than non infected diabetics, may be partly attributed to alteration of gastric mucosa as high prevalence of severe acute gastric inflammation. H pylori gastritis has been found to increase glucose and meal stimulated insulin release probably by increasing gastrin secretion (44) .
Chen and Blaser believe that H pylori directly or indirectly Increases HBAlc levels in adults, particularly
those who are obese, as H. pylori regulates leptin and ghrelin, which play a key role in energy homeostasis and metabolism (51).
CONCLUSION
The study reported no significant association between H. pylori infection and the prevalence of diabetes, but H. pylori infection was associated with a borderline increased risk for diabetes among participants with a BMI greater than 25kg/m².
